Correlation Between Eledon Pharmaceuticals and Mereo BioPharma
Can any of the company-specific risk be diversified away by investing in both Eledon Pharmaceuticals and Mereo BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eledon Pharmaceuticals and Mereo BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eledon Pharmaceuticals and Mereo BioPharma Group, you can compare the effects of market volatilities on Eledon Pharmaceuticals and Mereo BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eledon Pharmaceuticals with a short position of Mereo BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eledon Pharmaceuticals and Mereo BioPharma.
Diversification Opportunities for Eledon Pharmaceuticals and Mereo BioPharma
-0.35 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Eledon and Mereo is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Eledon Pharmaceuticals and Mereo BioPharma Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mereo BioPharma Group and Eledon Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eledon Pharmaceuticals are associated (or correlated) with Mereo BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mereo BioPharma Group has no effect on the direction of Eledon Pharmaceuticals i.e., Eledon Pharmaceuticals and Mereo BioPharma go up and down completely randomly.
Pair Corralation between Eledon Pharmaceuticals and Mereo BioPharma
Given the investment horizon of 90 days Eledon Pharmaceuticals is expected to generate 1.71 times less return on investment than Mereo BioPharma. In addition to that, Eledon Pharmaceuticals is 1.11 times more volatile than Mereo BioPharma Group. It trades about 0.04 of its total potential returns per unit of risk. Mereo BioPharma Group is currently generating about 0.07 per unit of volatility. If you would invest 99.00 in Mereo BioPharma Group on October 20, 2024 and sell it today you would earn a total of 187.00 from holding Mereo BioPharma Group or generate 188.89% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Eledon Pharmaceuticals vs. Mereo BioPharma Group
Performance |
Timeline |
Eledon Pharmaceuticals |
Mereo BioPharma Group |
Eledon Pharmaceuticals and Mereo BioPharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Eledon Pharmaceuticals and Mereo BioPharma
The main advantage of trading using opposite Eledon Pharmaceuticals and Mereo BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eledon Pharmaceuticals position performs unexpectedly, Mereo BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mereo BioPharma will offset losses from the drop in Mereo BioPharma's long position.Eledon Pharmaceuticals vs. Inozyme Pharma | Eledon Pharmaceuticals vs. Day One Biopharmaceuticals | Eledon Pharmaceuticals vs. Terns Pharmaceuticals | Eledon Pharmaceuticals vs. Hookipa Pharma |
Mereo BioPharma vs. Terns Pharmaceuticals | Mereo BioPharma vs. PDS Biotechnology Corp | Mereo BioPharma vs. Inozyme Pharma | Mereo BioPharma vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |